Related Experiment Videos
Pitfalls in lactate measurements at 3T.
T Lange1, U Dydak, T P L Roberts
1Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.
AJNR. American Journal of Neuroradiology
|April 14, 2006
Summary
High-field magnetic resonance spectroscopy (MRS) can cause false-negative lactate detection at 144 ms echo time. This study experimentally verifies lactate signal loss in phantom and patient data, impacting clinical interpretation.
Area of Science:
- Medical imaging
- Spectroscopy
- Biochemistry
Background:
- Clinical magnetic resonance spectroscopy (MRS) is crucial for metabolic profiling.
- Higher field strengths in MRS can alter signal characteristics.
- Lactate detection is important for diagnosing various conditions.
Purpose of the Study:
- To experimentally verify the predicted signal loss of lactate in clinical MRS at higher field strengths.
- To assess the potential for false-negative results in lactate detection.
- To investigate strategies for overcoming signal loss in MRS.
Main Methods:
- Utilized magnetic resonance spectroscopy (MRS) across scanners from three major vendors.
- Acquired spectra from both phantom samples and human patients.
- Analyzed signal intensity of lactate at an echo time of 144 ms.
Main Results:
- Demonstrated significant reduction or absence of lactate signal intensity at 144 ms echo time.
- Confirmed the theoretical prediction of lactate signal loss in experimental settings.
- Highlighted the potential for misinterpretation of clinical MRS data due to this artifact.
Conclusions:
- Lactate signal loss in high-field MRS at 144 ms echo time is a validated phenomenon.
- This signal loss can lead to false-negative results and diagnostic errors.
- Strategies to mitigate this issue are crucial for accurate clinical MRS interpretation.